Lipid oxidation products in cell signaling

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1370-1378

  Leonarduzzi, Gabriella ^a   Arkan, Melek C ^a,b   Basaga, Huveyda ^b   Chiarpotto, Elena ^a   Sevanian, Alex ^c   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SABANCI UNIVERSITY   (Turkey)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

4 Hydroxynonenal; Atherosclerosis; Fibrosclerosis; Free radicals; Lipid peroxidation; Ox LDL; Oxysterols; Transforming growth factor 1

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; FREE RADICAL; LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR AP 1;

ATHEROSCLEROTIC PLAQUE; CELL ACTIVITY; CELL COMMUNICATION; CELL FUNCTION; CELLULAR DISTRIBUTION; GENETIC TRANSCRIPTION; HUMAN; LIPID OXIDATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034190302     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00216-1     Document Type: Article

References (81)

1. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
2. Aviram M., Fuhrman B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells role of pro-oxidants vs. antioxidants . Mol. Cell. Biochem. 188:1998;149-159.
3. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low-density lipoprotein hypothesis . Atherosclerosis. 141:1998;1-15.
4. Steinbrecher U.P. Receptors for oxidized low-density lipoproteins. Biochim. Biophys. Acta. 1436:1999;279-298.
5. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
6. Weisser B., Locker R., Mengden T., Vetter W. Oxidation of low-density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler. Thromb. 12:1992;231-236.
7. Nègre-Salvayre A., Fitoussi G., Réaud V., Pieraggi M.T., Thiers J.C., Salvayre R. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in cultured bovine aortic endothelial cells. FEBS Lett. 299:1992;60-65.
8. Wells K.E., Alexander J.J., Miguel R. Calcium-dependent second-messenger regulation of low-density lipoprotein oxidation by human aortic smooth muscle cells. Surgery. 120:1996;337-344.
9. Resink T.J., Tkachuk V.A., Bernhardt J., Bühler F.R. Oxidized low-density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler. Thromb. 12:1992;278-285.
10. Thorin E., Hamilton C.A., Dominiczak M.H., Reid J.L. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release. Arterioscler. Thromb. 14:1994;453-459.
11. Natarajan V., Sribner W.M., Hart C.M., Parthasarathy S. Oxidized low-density lipoprotein-mediated activation of phospholipase D in smooth muscle cells a possible role in cell proliferation and atherogenesis . J. Lipid Res. 36:1995;2005-2016.
12. Fyrnys B., Claus R., Wolf G., Deigner H.P. Oxidized low-density lipoprotein stimulates protein kinase C (PKC) activity and expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 cells. Adv. Exp. Med. Biol. 407:1997;93-98.
13. Encabo A., Ferrer M., Conde M.V., Porres A., Gomez-Gerique J.A., Marin J., Balfagon G. Involvement of protein kinase C in the supersensitivity to 5-HT caused by oxidized low-density lipoproteins. Life Sci. 61:1997;1331-1339.
14. Yoshida N., Yoshikawa T., Manabe H., Terasawa Y., Kondo M., Noguchi N., Niki E. Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells. J. Leukoc. Biol. 65:1999;757-763.
15. Biwa T., Hakamata H., Sakai M., Miyazaki A., Suzuki H., Kodama T., Shichiri M., Horiuchi S. Induction of murine macrophage growth by oxidized low-density lipoprotein is mediated by granulocyte-macrophage colony-stimulating factor. J. Biol. Chem. 273:1998;28305-28313.
16. Matsumura T., Sakai M., Kobori S., Biwa T., Takemura T., Matsuda H., Hakamata H., Horiuchi S., Shichiri M. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler. Thromb. Vasc. Biol. 17:1997;1020-3013.
17. Suc I., Meilhac O., Lajoie-Mazenc I., Vandaele J., Jürgens G., Salvayre R., Nègre-Salvayre A. Activation of EGF receptor by oxidized LDL. FASEB J. 12:1998;665-671.
18. Ballou L.R., Laulederkind S.J., Rosloniec E.F., Raghow R. Ceramide signalling and the immune response. Biochim. Biophys. Acta. 1301:1996;273-287.
19. Spiegel S., Merrill A.H. Jr. Sphingolipid metabolism and cell growth regulation. FASEB J. 10:1996;1388-1397.
20. Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18:1998;1523-1533.
21. Augé N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrézou J.P., Laurent G., Levade T., Nègre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low-density lipoprotein. J. Biol. Chem. 273:1998;12893-12900.
22. Deigner H.P., Claus R. Stimulation of mitogen-activated protein kinase by LDL and ox-LDL in human U-937 macrophage-like cells. FEBS Lett. 385:1996;149-153.
23. Kusuhara M., Chait A., Cader A., Bradford C.B. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 17:1997;141-148.
24. Jing Q., Xin S.M., Cheng Z.J., Zhang R., Qin Y.W., Pei G. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity . Circ. Res. 84:1999;831-839.
25. Huang Y., Jaffa A., Koskinen S., Takei A., Lopez-Virella M.F. Oxidized LDL-containing immune complexes induces Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 19:1999;1600-1607.
26. Martens J.S., Reiner N.E., Herrera-Velit P., Steinbrecher U.P. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low-density lipoprotein. J. Biol. Chem. 273:1998;4915-4920.
27. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands the JAK-STAT pathway . Ann. Rev. Biochem. 64:1995;621-651.
28. Maziére C., Alimardani G., Dantin F., Dubois F., Conte M.A., Mazière J.C. Oxidized LDL activates STAT1 and STAT3 transcription factors possible involvement of reactive oxygen species . FEBS Lett. 448:1999;49-52.
29. Khan B.V., Parthasarathy S.S., Alexander R.W., Medford R.M. Modified low-density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1995;1262-1270.
30. Kamanna V.S., Pai R., Ha H., Kirschenbaum M.A., Roh D.D. Oxidized low-density lipoprotein stimulates monocyte adhesion to glomerular endothelial cells. Kidney Int. 55:1999;2192-2202.
31. Weber C., Erl W., Weber K.S., Weber P.C. Effects of oxidized low-density lipoprotein, lipid mediators and statins on vascular cell interactions. Clin. Chem. Lab. Med. 37:1999;243-251.
32. Maziére C., Djavaheri-Margny M., Frey-Fressart V., Delattre J., Mazière J.C. Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells. FEBS Lett. 409:1997;351-356.
33. Maziére C., Auclair M., Djavaheri-Margny M., Packer L., Mazière J.C. Oxidized low-density lipoprotein induces activation of the transcription factor NF-κB in fibroblasts, endothelial, and smooth muscle cells. Biochem. Mol. Biol. Int. 39:1996;1201-1207.
34. Sugiyama S., Kugiyama K., Ogata N., Doi H., Ota Y., Ohgushi M., Matsumura T., Oka H., Yasue H. Biphasic regulation of transcription factor nuclear factor κB activity in human endothalial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler. Thromb. Vasc. Biol. 18:1998;568-576.
35. Yamakawa T., Eguchi S., Yamakawa Y., Motley E.D., Numaguchi K., Utsunomiya H., Inagami T. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Hypertension. 31:1998;248-253.
36. Ricote M., Huang J., Faias L., Li A., Welch J., Najib J., Witzum J.L., Auwerx J., Palinski W., Glass C.K. Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low-density lipoproteins. Proc. Natl. Acad. Sci. USA. 95:1998;7614-7619.
37. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
38. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell. 93:1998;229-240.
39. Schauenstein E., Esterbauer H., Zollner H. Aldehydes in biological systems their natural occurrence and biological activities . 1977;Pion Ltd, London.
40. Benedetti A., Comporti M., Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta. 620:1980;281-296.
41. Dianzani M.U. Biochemical effects of saturated and unsaturated aldehydes. McBrien D.C.H., Slater T.F., Free radicals, lipid peroxidation and cancer. 1982;129-158 Academic Press, London.
42. Poli G., Dianzani M.U., Cheeseman K.H., Slater T.F., Lang J., Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227:1985;629-638.
43. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
44. Esterbauer H., Benedetti A., Lang J., Fulceri R., Fauler G., Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim. Biophys. Acta. 876:1986;154-166.
45. Dianzani M.U. 4-Hydroxynonenal and cell signalling. Free Radic. Res. 28:1998;553-560.
46. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
47. Paradis V., Kollinger M., Fabre M., Holstege A., Poynard T., Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology. 26:1997;135-142.
48. Smith R.G., Henry Y.K., Mattson M.P., Appel S.H. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 44:1998;696-699.
49. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low-density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100:1997;2680-2690.
50. Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R., Poli G. Vitamin E dietary supplementation inhibits transforming growth factor β1 gene expression in the rat liver. FEBS Lett. 308:1992;267-270.
51. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogl S., Dargel R., Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal upregulates transforming growth factor β1 expression in the macrophage lineage a link between oxidative injury and fibrosclerosis . FASEB J. 11:1997;851-857.
52. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha (I) expression and synthesis in human liver fat storing cells. Biochim. Biophys. Res. Commun. 194:1993;1044-1050.
53. Kamimura S., Gaal K., Britton R.S., Bacon B.R., Triadafilopoulos G., Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease association of lipid peroxidation with liver fibrogenesis . Hepatology. 16:1992;448-453.
54. Houglum, K.; Bedossa, P.; Chojkier, M. TGF-beta and collagen-alpha (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am. J. Physiol. 267:G908-913; 1984.
55. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22:1997;287-305.
56. Cajone F., Bernelli-Zazzera A. The action of 4-hydroxynonenal on heat shock gene expression in cultured hepatoma cells. Free Radic. Res. Commun. 7:1989;189-194.
57. Fazio V.M., Barrera G., Martinotti S., Farace M.G., Giglioni B., Frati L., Manzari V., Dianzani M.U. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res. 52:1992;4866-4871.
58. Spycher S.E., Tabataba-Vakili S., O'Donnell V.B., Palomba L., Azzi A. 4-Hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase. Biochem. Biophys. Res. Commun. 226:1996;512-516.
59. Spycher S.E., Tabataba-Vakili S., O'Donnell V.B., Palomba L., Azzi A. Aldose reductase reduction a novel response to oxidative stress of smooth muscle cells . FASEB J. 11:1997;181-188.
60. Liu R.M., Gao L., Choi J., Forman H.J. Gamma-glutamylcysteine synthetase mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal . Am. J. Physiol. 275:1998;L861-L869.
61. Kim S.J., Dehnez F., Kim K.Y., Holt J.T., Sporn M.B., Roberts A.B. Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264:1989;19373-19378.
62. Armendariz-Borunda J., Simkevich C.P., Roy N., Raghow R., Kang A.H., Seyer J.M. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem. J. 304:1994;817-824.
63. Camandola S., Scavazza A., Leonarduzzi G., Biasi F., Chiarpotto E., Azzi A., Poli G. Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-κB in cells of the macrophage lineage. Biofactors. 6:1997;173-179.
64. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi G., Camandola S., Poli G., Waeg G., Gentilini P., Dianzani M.U. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102:1998;1942-1950.
65. Page S., Fischer C., Baumgartner B., Haas M., Kreusel U., Loidl G., Hayn M., Löms Ziegler-Heitbrock H.W., Neumeier D., Brand K. 4-Hydroxynonenal prevents NF-κB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis. J. Biol. Chem. 274:1999;11611-11618.
66. Camandola, S.; Poli, G.; Mattson, M. P. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1 binding activity through caspase activation in neurones. J. Neurochem. 74:159-168; 2000.
67. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274:1999;2234-2242.
68. Grune T., Reinheckel T., Joshi M., Davies K.J. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270:1995;2344-2351.
69. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation. 97:1998;1071-1078.
70. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M., Pronzato M.A., Biasi F., Cottalasso D., Marinari U.M., Dragonetti A., Cesaro P., Isidoro C., Poli G. Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal a signaling pathway to modulate vesicular transport of glycoproteins . Hepatology. 29:1999;1565-1572.
71. Curzio M., Ferretti C., Stephens R.J., Esterbauer H., Dianzani M.U. Binding of the lipid peroxidation product 4-hydroxynonenal to human polymorphonuclear leukocytes. Cell Biochem. Func. 12:1994;57-62.
72. Buko V.U., Artsukevich A., Zavodnik I., Maltsev A., Sushko L., Zimmermann T., Dianzani M.U. Interactions of malondialdehyde and 4-hydroxynonenal with rat liver plasma membranes and their effect on binding of prostaglandin E2 by specific receptors. Free Radic. Res. 25:1996;415-420.
73. Nakamura T., Datta R., Sherman M.L., Kufe D. Regulation of c-jun gene expression by cAMP in HL-60 myeloid leukemia cells. J. Biol. Chem. 265:1990;22011-22015.
74. Hodis H.N., Crawford D.W., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel further evidence for the role of cholesterol oxidation in atherosclerosis . Atherosclerosis. 89:1991;117-126.
75. Brown A.J., Leong S.-L., Dean R.T., Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low-density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38:1997;1730-1745.
76. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 142:1999;1-28.
77. Hodis H.N., Kramsch D.M., Avogaro P., Bittolo-Bon G., Cazzolato G., Hwang J., Peterson H., Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low-density lipoprotein (LDL-). J. Lipid Res. 35:1994;669-677.
78. Kraemer R., Pomerantz K.B., Joseph-Silverstein J., Hajjar D.P. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. J. Biol. Chem. 268:1993;8040-8045.
79. Kritharides L., Upston J., Jessup W., Dean R.T. Accumulation and metabolism of low-density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages. J. Lipid Res. 39:1998;2394-2405.
80. Hoppe G., Ravandi A., Herrera D., Kuksis A., Hoff H.F. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J. Lipid Res. 38:1997;1347-1360.
81. Karten B., Boechzelt H., Abuja P.M., Mittelbach M., Oettl K., Sattler W. Femtomole analysis of 9-oxononanoyl cholesterol by high performance liquid chromatography. J. Lipid Res. 39:1998;1508-1519.